Pulse استكشاف nav.journalClub النقاشات الرائج الباحثون المجلات

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

الرئيسية استكشاف nav.journalClub الرائج

⌘+K

Central Serous Chorioretinopathy in Patients Receiving Exogenous Testosterone Therapy | Synapse

June 19, 2014

View Full Paper

Central Serous Chorioretinopathy in Patients Receiving Exogenous Testosterone Therapy

ENEric NudlemanUniversity of California, San Diego MWMatthew T. WitmerMemorial Sloan Kettering Cancer Center SKSzilárd KissSemmelweis University

Key Points

Key points are not available for this paper at this time.

Abstract

Exogenous testosterone may be an independent risk factor for the development of CSCR.

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

Cite This Study

Nudleman et al. (Thu,) studied this question.

synapsesocial.com/papers/69de8aab353721b241b0c1cd https://doi.org/https://doi.org/10.1097/iae.0000000000000198

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The age‐related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction2009 · 121 citations
2Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients.1993 · 107 citations
3Effect of acute testosterone on myocardial ischemia in men with coronary artery disease1999 · 240 citations
4Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.1991 · 78 citations
5Central Serous Chorioretinopathy in Endogenous Hypercortisolism1993 · 242 citations